Author Response

Authors’ Response

Authors: Therese S. Geraci, MSN, Stephen A. Geraci, MD

Abstract

To the Editor

We thank Alkhuja and colleagues for their interest in our article “Considerations in Women with Hypertension.”1 We agree that the association among the comorbidities of hypertension, obesity, and obstructive sleep apnea (OSA) is well established. The sex-specific degree of interaction among these variables has not, however, been well studied. The presence of obesity is strongly associated with the development of hypertension.2 Epidemiologic evidence also supports an association between sleep-disordered breathing and hypertension3; however, data specifically addressing high blood pressure in patients with OSA, stratified by the presence of obesity, are scarce.4Epidemiologic association and longitudinal cohort studies provide evidence that OSA poses an increased risk for adverse health outcomes, including cardiovascular disease and total mortality.3,5Obesity has been associated with OSA, and in both sexes, an increasing body mass index correlates positively with severity of this disease.6 Although data from the 1999–2002 National Health and Nutrition Examination Survey indicated more women (33.4%) than men (27.3%) have a body mass index ≥30, women did not have higher rates of OSA.6

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Geraci TS, Geraci SA. Considerations in women with hypertension. South Med J. 2013; 106: 434–438.
 
2. Cutler JA, Sorlie PD, Wolz M, et al. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension. 2008; 52: 818–827.
 
3. Pack AI, Gislason T. Obstructive sleep apnea and cardiovascular disease: a perspective and future directions. Prog Cardiovasc Dis. 2009; 51: 434–451.
 
4. Drager LF, Togeiro SM, Polotsky VY, et al. Obstructive sleep apnea: a cardiometabolic risk in obesity and metabolic syndrome. J Am Coll Cardiol. 2013; 62: 569–576.
 
5. Marin JM, Agusti A, Villar I, et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA. 2012; 307: 2169–2176.
 
6. Lin CM, Davidson TM, Ancoli-Israel S. Gender differences in obstructive sleep apnea and treatment implications. Sleep Med Rev. 2008; 12: 481–496.